Print

HVTN 098

NCT02431767

Trial Details:

I Completed
HIV Vaccine Trials Network (HVTN); NIAID
PENNVAX-GP
Healthy adults
RandD/trials/Lists/ClinicalTrialsList
11/1/2017
Gag, Pol, Env B
PENNVAX®-GP vaccine 0.6 mg admixed with IL-12 DNA 0.2 mg to be administered as 0.1 mL by intradermal (ID) injection over either deltoid at Months 0, 1, 3, and 6 using the CELLECTRA® 3P EP system. OR PENNVAX®-GP vaccine 0.8 mg to be administered as 0.1 mL